Certified by Founder Lodge
Nodus Oncology
United Kingdom - Edinburgh, Midlothian
START UP
1 Disclosed Funding Rounds $2,911,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Nodus oncology is developing first and best-in-class molecules inhibiting novel targets within the DNA damage response and replication stress response.
Supported by most recent scientific ad
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 10 ,2023 | Unknown | $2,911,000 |
KHAN Technology Transfer Fund I
Cumulus Oncology
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Whirl AI | $8,900,000 | (Apr 2, 2026)
Cara | $8,000,000 | (Apr 2, 2026)
Sona(UK) | $45,000,000 | (Apr 2, 2026)
TippingPoint Biosciences | $4,500,000 | (Apr 2, 2026)
Rowan(US) | $3,300,000 | (Apr 2, 2026)
